Dyne Therapeutics (DYN)
NASDAQ:DYN
US Market
Holding DYN?
Track your performance easily

Dyne Therapeutics (DYN) Financial Statements

292 Followers

Dyne Therapeutics Financial Overview

Dyne Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.584; its P/E ratio is -7.95; Dyne Therapeutics is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -71.96M$ -69.16M$ -67.69M$ -62.27M$ -64.90M
EBITDA$ -71.56M$ -68.77M$ -67.29M$ -61.84M$ -64.83M
Net Income Common Stockholders$ -65.10M$ -65.65M$ -66.64M$ -60.21M$ -64.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 778.84M$ 453.55M$ 123.10M$ 157.82M$ 207.73M
Total Assets$ 825.88M$ 522.28M$ 165.08M$ 205.24M$ 251.42M
Total Debt$ 25.72M$ 26.62M$ 27.41M$ 28.23M$ 29.04M
Net Debt$ -753.12M$ -426.93M$ -95.69M$ -129.60M$ -178.70M
Total Liabilities$ 50.69M$ 44.22M$ 73.79M$ 53.21M$ 44.54M
Stockholders Equity$ 775.19M$ 478.06M$ 91.29M$ 152.04M$ 206.88M
Cash Flow-
Free Cash Flow$ -55.73M$ -78.73M$ -35.09M$ -50.77M$ -55.89M
Operating Cash Flow$ -54.87M$ -78.54M$ -35.01M$ -50.60M$ -55.64M
Investing Cash Flow$ 11.17M$ -179.84M$ 26.20M$ 12.82M$ 17.23M
Financing Cash Flow$ 379.86M$ 408.39M$ 147.00K$ 454.00K$ 24.91M
Currency in USD

Dyne Therapeutics Earnings and Revenue History

Dyne Therapeutics Debt to Assets

Dyne Therapeutics Cash Flow

Dyne Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis